Abstract: Provided are certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.

Abstract: The embodiments are directed towards providing personalized federated learning (PFL) models via sharable federated basis models. A model architecture and learning algorithm for PFL models is disclosed. The embodiments learn a set of basis models, which can be combined layer by layer to form a personalized model for each client using specifically learned combination coefficients. The set of basis models are shared with each client of a set of the clients. Thus, the set of basis models is common to each client of the set of clients. However, each client may generate a unique PFL based on their specifically learned combination coefficients. The unique combination of coefficients for each client may be encoded in a separate personalized vector for each of the clients.

Abstract: Disclosed are an image matching method and apparatus. The image matching method is inclusive of steps of obtaining a panoramic image of at least one subspace in a 3D space and a 2D image of the 3D space; acquiring a 2D image of the at least one subspace in the 3D space; performing 3D reconstruction on the panoramic image of the at least one subspace, and procuring a projection image corresponding to the panoramic image of the at least one subspace; and attaining a matching relationship between the panoramic image of the at least one subspace and the 2D image of the at least one subspace, and establishing an association relationship between the panoramic image of the at least one subspace and the 2D image of the at least one subspace between which the matching relationship has been generated.

Abstract: Disclosed is a method and system for predicting a touch interaction position on a large display based on a binocular camera. The method includes: separately acquiring arm movement video frames of a user and facial and eye movement video frames of the user by a binocular camera; extracting a video clip of each tapping action from the arm movement video frames and the facial and eye movement video frames and obtaining a key frame by screening; marking the key frame of each tapping action with coordinates to indicate coordinates of a finger in a display screen; inputting the marked key frame to an efficient convolutional network for online video understanding (ECO)-Lite neural network for training to obtain a predictive network model; and inputting a video frame of a current operation to be predicted to the predictive network model and outputting a touch interaction position predicted for the current operation.

Abstract: Provided are certain triazolopyridines and triazolopyrazines of Formula 1, wherein X, Y, R1, R2, R3, R4 and R5 have any of the meanings described herein; processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of cell proliferative disorders.

Abstract: Provided are a canine parvovirus (CPV) nanobody CPV-VHH-E3 and application thereof, belonging to the technical field of immunology. The nanobody CPV-VHH-E3 includes heavy chain variable region with amino acid sequence as shown in SEQ ID NO: 1, and a nucleotide sequence of a gene encoding the nanobody CPV-VHH-E3 is shown in SEQ ID NO: 2. The present application constructs a nanobody immune library for CPV by phage-display technology, and obtains specific anti-CPV nanobody CPV-VHH-E3 by screening, which is verified to specifically bind CPV through experiments, and is applicable to develop a nanobody preparation for clinical diagnosis and treatment of CPV, providing a certain theoretical support for the application of nanobodies in the field of veterinary biological products.

Abstract: Provided are a canine parvovirus (CPV) nanobody CPV-VHH-E3 and application thereof, belonging to the technical field of immunology. The nanobody CPV-VHH-E3 includes heavy chain variable region with amino acid sequence as shown in SEQ ID NO: 1, and a nucleotide sequence of a gene encoding the nanobody CPV-VHH-E3 is shown in SEQ ID NO: 2. The present application constructs a nanobody immune library for CPV by phage-display technology, and obtains specific anti-CPV nanobody CPV-VHH-E3 by screening, which is verified to specifically bind CPV through experiments, and is applicable to develop a nanobody preparation for clinical diagnosis and treatment of CPV, providing a certain theoretical support for the application of nanobodies in the field of veterinary biological products.

Abstract: The present disclosure provides a canine parvovirus (CPV) nanobody CPV-VHH-H1 and use thereof, belonging to the technical field of immunology. A heavy-chain variable region sequence of the nanobody CPV-VHH-H1 has the amino acid sequence set forth in SEQ ID NO: 1; and a gene encoding the nanobody CPV-VPP-H1 has the nucleotide sequence set forth in SEQ ID NO: 2. In the present disclosure, a nanobody immune library of the CPV is constructed by a phage display technology, a specific anti-CPV nanobody CPV-VHH-H1 is obtained by screening, and it is verified by experiments that the nanobody may specifically bind to the CPV. The present disclosure is expected to develop a new nanobody preparation for use in clinical diagnosis and treatment of the CPV, and provides a certain theoretical reserve for applying the nanobody to the field of veterinary biological products.

Abstract: The present disclosure provides a recombinant adenovirus for expressing African swine fever virus (ASFV) EP153R-EP402R protein and a construction method thereof, and belongs to the technical field of genetic engineering. In the present disclosure, a recombinant adenovirus vector pAD-CMV-EGFP-EP153R-EP402R is obtained through a series of intermediate processes using a recombinant adenovirus shuttle vector pENTRE-EGFP-TOPO; the recombinant adenovirus vector is linearized to transfect AD293 cells, a recombinant virus is screened according to cytopathy formed by adenovirus infection, an adenovirus packaging process is achieved, and the recombinant adenovirus for expressing ASFV EP153R-EP402R protein is obtained, laying a foundation for the construction of a recombinant adenovirus vaccine for expressing the ASFV EP153R-EP402R protein.

Abstract: Methods, systems, and storage media are provided for accessibility services to assist users with disabilities in using touch-based interfaces and graphical user interfaces (GUIs). A client system generates and renders a GUI of a client application that comprises one or more graphical objects. The client system operates a service to identify graphical objects that refer or link to advertisements or other third party resources. The service applies a protective measure to the identified graphical objects, which prevent user inputs (e.g., “taps”) from being accepted by the client system. The protective measure may include a distinguishing effect to visually distinguish the protective measure from other graphical objects in the GUI. The user may remove the protective measure by performing a predefined gesture. Other embodiments may be described and/or claimed.

Abstract: Methods, systems, and storage media are described for indicating deceptive or trustworthy resources are provided. A client system generates and renders a graphical user interface (GUI) comprising one or more graphical objects in a client application. The client system identifies resources corresponding to individual graphical objects. The client system communicates the identified resources to a reputation system, and obtains indicators indicating deceptive resources to be obfuscated and/or trustworthy resources to be illuminated. The client system obfuscates the deceptive resources and illuminates the trustworthy resources according to the received indicators. Other embodiments may be described and/or claimed.

Abstract: Methods, systems, and storage media are provided for accessibility services to assist users with disabilities in using touch-based interfaces and graphical user interfaces (GUIs). A client system generates and renders a GUI of a client application that comprises one or more graphical objects. The client system operates a service to identify graphical objects that refer or link to advertisements or other third party resources. The service applies a protective measure to the identified graphical objects, which prevent user inputs (e.g., “taps”) from being accepted by the client system. The protective measure may include a distinguishing effect to visually distinguish the protective measure from other graphical objects in the GUI. The user may remove the protective measure by performing a predefined gesture. Other embodiments may be described and/or claimed.

Abstract: Methods, systems, and storage media for distinguishing third party resources (TPRs) with respect to first party resources (FPRs) are provided. A client system generates and renders a graphical user interface (GUI) comprising one or more graphical objects in a client application. The client system identifies resources corresponding to individual graphical objects. The client system communicates the identified resources to a verification service, and obtains indicators indicating TPRs to be distinguished from FPRs. The client system applies a distinguishing effect to the TPRs based on the received indicators. Other embodiments may be described and/or claimed.

Abstract: Provided are certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.

Abstract: Provided are certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.

Abstract: Automated malware signature generation is disclosed. Automated malware signature generation includes monitoring incoming unknown files for the presence of malware and analyzing the incoming unknown files based on both a plurality of classifiers of file behavior and a plurality of classifiers of file content. An incoming file is classified as having a particular malware classification based on the analyzing of incoming unknown files and a malware signature is generated for the incoming unknown file based on the particular malware classification. Access is provided to the malware signature.

Abstract: The present invention provides diagnostic markers for Bovine tuberculosis and uses thereof. In the present invention, markers capable of differentiating Bovine tuberculosis negative or positive are obtained by screening with untargeted proteomic techniques and verifying with targeted proteomic techniques, which are IL-8, CRP. The diagnostic markers for Bovine tuberculosis provided in the present invention can identify whether the cattles to test are Bovine tuberculosis negative or positive, and whether positive tuberculosis cattles are at discharge period of bacteria. The diagnostic markers can be used in the preparation of kits or reagents for detecting Bovine tuberculosis, thus providing new detection targets for the diagnosis of Bovine tuberculosis, which is helpful to the prompt detection and elimination of tuberculosis cattles, also ensuring the comprehensive prevention and control of Bovine tuberculosis.

Abstract: Methods, systems, and storage media are described for indicating deceptive or trustworthy resources are provided. A client system generates and renders a graphical user interface (GUI) comprising one or more graphical objects in a client application. The client system identifies resources corresponding to individual graphical objects. The client system communicates the identified resources to a reputation system, and obtains indicators indicating deceptive resources to be obfuscated and/or trustworthy resources to be illuminated. The client system obfuscates the deceptive resources and illuminates the trustworthy resources according to the received indicators. Other embodiments may be described and/or claimed.

Abstract: Methods, systems, and storage media for distinguishing third party resources (TPRs) with respect to first party resources (FPRs) are provided. A client system generates and renders a graphical user interface (GUI) comprising one or more graphical objects in a client application. The client system identifies resources corresponding to individual graphical objects. The client system communicates the identified resources to a verification service, and obtains indicators indicating TPRs to be distinguished from FPRs. The client system applies a distinguishing effect to the TPRs based on the received indicators. Other embodiments may be described and/or claimed.

Abstract: Provided are certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.